ARC Group has a distinguished history of guiding companies through successful public listings and strategic transactions.

  • ARC Group provides a comprehensive suite of financial advisory services including IPOs, equity and debt financing, SPACs, and more.
  • With a proven track record in managing complex transactions, cross-border listings, and specialized capital strategies, we help businesses navigate an ever-evolving financial landscape.
  • ARC Group’s Capital Markets approach is built on tailored strategies that empower our clients to bolster their market presence, secure the right financing, and sustain long-term growth.
  • In 2022 ARC Group was Global leader in DeSPAC by both transaction number and value according to SPAC Market Data by SPACInsider.
A developer looks at process data on a screen

Our elite team of seasoned
professionals brings
extensive expertise in
capital markets.

Our Capital Market Advisory Services

Public Listing Advisory for:

  • Initial Public Offering (IPO)
  • SPAC listing
  • Direct listing
  • DeSPAC
  • Reverse Takeover (RTO)

Capital Raising Advisory for:

  • Equity and Debt Financing
  • Private Investment in Public Equity (PIPE)
  • Registered Direct Offering
  • Follow-on Offerings
  • At-the-Market Offering
  • Convertible Equity & Debt
  • Equity Line of Credit (ELOC)
  • Fixed Income Offering

Other Services for Public Companies:

  • Accounting
  • SEC compliance
  • Non-Deal Roadshows

Underwriting Capabilities

ARC Group strengthens its global capital markets platform through ARC Group Securities LLC, a wholly owned subsidiary and U.S.-registered broker-dealer with underwriting rights. This allows us to underwrite IPOs and public offerings directly, providing clients with seamless access to U.S. capital markets and a fully integrated advisory-to-execution solution.

Latest Transactions

Shuttle Pharmaceuticals Holdings, Inc.

NASDAQ: SHPH

Shuttle Pharmaceuticals Holdings, Inc.
Total PIPE $11M

ARC Group acted as Co-Investor to Shuttle Pharmaceuticals Holdings, Inc.
May 2026

iSpecimen Inc.

NASDAQ: ISPC

iSpecimen Inc.
Total PIPE $2.5M

ARC Group acted as Co-Investor to iSpecimen Inc.
May 2026

ARC Group Acquisition I

NASDAQ: ARCLU

ARC Group Acquisition I
IPO $120.75M

ARC Group Securities LLC acted as Lead Left Bookrunner
May 2026

Magnax BV

Magnax BV
Capital Raise €35.5M

ARC Group acted as Exclusive Financial Advisor to Magnax BV
April 2026

Why Choose ARC Group?

Global Reach

With 13 offices strategically placed around the world, we ensure unparalleled support and seamless access to international markets. Our extensive global network enables us to expertly manage cross-border transactions, offering exceptional opportunities for growth and expansion.

Experienced Team

Our elite team of seasoned professionals brings extensive expertise in capital markets. Their deep industry knowledge and innovative approach allow us to deliver optimal results, tailored strategies, and insightful solutions, addressing the unique needs of each client with precision.

Consistent Track Record

Consistently ranked at the top of league tables, our firm is recognized for its excellence, reliability, and ability to achieve outstanding outcomes. We ensure our clients reach new heights of success and accomplish their financial goals with confidence.

Ian Hannah

Ian Hanna

Managing Director

Ready to connect with us?

Please complete this form to download the case study

This field is for validation purposes and should be left unchanged.
*Required before submission